HC Wainwright & Co. Reiterates Spectrum Pharmaceuticals (SPPI) Neutral Recommendation
27/5 01:27
Fintel reports that on May 26, 2023, HC Wainwright & Co. reiterated coverage of Spectrum Pharmaceuticals (NASDAQ:SPPI) with a Neutral recommendation....